Each CD includes the full-color, searchable, PDF files of articles and formulations from the Journal.

CD Prices
1 = $95
2 to 5 = $85 each
6 to 9 = $75 each
10 + = $65 each

PEDIATRICS AND GERIATRICS
PEDIATRICS AND GERIATRICS Permanent storage and easy retrieval of Journal articles and formulations.
Only $95 per CD
  • Print Journal articles in color from the pdf file for your marketing needs.
  • Eliminate long searches through past issues for articles and formulations.

This CD contains the following articles listed by volume, issue and page number:

PEDIATRICS RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Practicing Your Compounding Skills Outsides of Your Pharmacy's Walls Vol. 19 No. 3 205
L-Cysteine Hydrochloride 50-mg/mL Injection Vol. 19 No. 2 146
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition Vol. 18 No. 5 427
The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Vol. 18 No. 1 6
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 2 Vol. 17 No. 6 446
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms Vol. 17 No. 5 364
Disguising the Taste of Antiretrovirals for Pediatric Patients Infected with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome: Creative Flavor Compounding and Techniques, Part 1 Vol. 17 No. 5 388
Indomethacin 1-mg/mL Injection Vol. 17 No. 5 419
Pattern of Extemporaneous Prescriptions and Preparations in a Tertiary Health Institution: A Five-year Assessment Vol. 17 No. 5 432
Pediatric Health Care: An Introduction Vol. 17 No. 1 6
A Concise Discussion of Headache Types, Part 3: Migraine Vol. 16 No. 4 270
A Retrospective Observational Case Series Analysis of the Usage of Hydroxyprogesterone Caproate for the Prevention of Preterm Labor in Alabama Patients Vol. 15 No. 6 446
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers Vol. 15 No. 6 458
Diaper Rash Relief: Common Sense Remedies and Treatments Vol. 15 No. 6 464
Infantile Hemangiomas, Part 1: Treatment with Oral Propranolol Hydrochloride Vol. 15 No. 5 358
Updated Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Vol. 15 No. 5 386
Folinic Acid, L-DOPA, and 5-hydroxytryptophan in Tetrahydrobiopterin Deficiency: Treatment Plan for a Pediatric Patient Vol. 15 No. 4 316
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient Vol. 15 No. 3 194
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration Vol. 15 No. 3 200
Proton Pump Inhibitor Homogenous Suspensions: A Compounding Solution to Pediatric Gastroesophageal Reflux Disease Vol. 15 No. 2 124
Acetylcysteine 1% or 10% Oral Solution Vol. 15 No. 2 156
Glutathione 25% in Pluronic Lecithin Organogel Vol. 14 No. 6 518
Developing an Erythromycin Ophthalmic Ointment: Putting the Puzzle Pieces Together Vol. 14 No. 4 270
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet Vol. 14 No. 1 21
Diverse Challenges in Pediatric Compounding: Treating Pulmonary Hypertension, Uncombable Hair Syndrome, and Acanthamoeba keratitis Vol. 14 No. 1 40
When Traditional Medicine Fails Vol. 14 No. 1 6
Calculations Vol. 14 No. 1 58
Emanuel Butt Paste Vol. 13 No. 5 431
Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Vol. 13 No. 4 314
Compounding Naltrexone for the Treatment of Autism Vol. 13 No. 4 296
Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Vol. 13 No. 3 220
Compounding for Pediatric Patients: Case Reports and Formulations Vol. 13 No. 1 6
Evaluation of Dosage Form Information Provided in Pediatric Drug Trial Reports Vol. 13 No. 1 14
Calculations Vol. 13 No. 1 63
Acetaminophen, Pseudoephedrine Hydrochloride, and Chlorpheniramine Maleate Powder Packets Vol. 13 No. 1 64
Amphotericin B, Chloramphenicol Palmitate, Hydrocortisone, and Sulfanilamide Otic Powder Vol. 13 No. 1 65
Diaper Rash Cream with Miconazole Vol. 13 No. 1 68
Diphenhydramine Hydrochloride 25-mg Gelatin Troches Vol. 13 No. 1 69
Lack of Commercial Oral Drug Formulations for Children in Two Hospital Group Purchasing Agreements in France and Canada Vol. 12 No. 4 365
Benzyl Benzoate Lotion Vol. 12 No. 3 261
Valsartan 4-mg/mL Oral Liquid Vol. 12 No. 3 269
Trimethoprim 10-mg/mL Oral Suspension Vol. 12 No. 1 73
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Development--Pediatric Formulations Initiative, Part 2 Vol. 11 No. 3 220
Methylphenidate 1-mg/mL Oral Liquid Vol. 11 No. 3 249
Challenges of Compounding for Patients on the Ketogenic Diet Vol. 11 No. 2 116
Ranitidine Hydrochloride 15-mg/mL Oral Liquid Vol. 11 No. 2 161
Need for Appropriate Formulations for Children: The National Institute of Child Health and Human Developmentā€”Pediatric Formulations Initiative, Part 1 Vol. 11 No. 1 5
Principles of Pediatric Palliative Care and Pain Control Vol. 11 No. 1 10
Pediatric Oral Formulations: A Continual Challenge Vol. 11 No. 1 17
Sevelamer Suspension in Children with End-Stage Renal Disease Vol. 11 No. 1 20
Case Report: Cocktail Dosing in a Premature Infant with a History of Cholestasis Vol. 11 No. 1 26
Case Report: Treatment of Labial Adhesions in a Child Vol. 11 No. 1 27
Calculations Vol. 11 No. 1 68
Caffeine Citrate 10-mg/mL Oral Liquid Vol. 11 No. 1 69
Carbidopa 1.25-mg/mL Oral Liquid Vol. 11 No. 1 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Vol. 11 No. 1 71
Methyldopa 25-mg/mL Oral Liquid Vol. 11 No. 1 75
Metolazone 1-mg/mL Oral Liquid Vol. 11 No. 1 76
Prednisone 10-mg/mL Oral Liquid Vol. 11 No. 1 77
Prednisolone Sodium Phosphate 10-mg/mL Oral Liquid Vol. 11 No. 1 78
Nitrazepam 1-mg/mL Oral Liquid Vol. 10 No. 5 388
Oral Rehydration Salts (World Health Organization/United Nations Children's Fund) Vol. 10 No. 5 390
Adderall 1-mg/mL Oral Liquid Vol. 10 No. 4 299
Lisinopril 1-mg/mL Oral Liquid Vol. 10 No. 4 302
Nifedipine 4-mg/mL Oral Liquid Vol. 10 No. 4 303
Propranolol Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 4 304
Propylthiouracil 5-mg/mL Oral Liquid Vol. 10 No. 1 67
Prescription: Pediatric Formulation Initiatives Vol. 9 No. 6 410
Unlocking Autism: Is Compounding the Key? Vol. 9 No. 6 413
Compounding for a Pediatric Hospital Vol. 9 No. 6 423
Wiping Out Diaper Rash Vol. 9 No. 6 433
Pediatric Oral Liquid Preparations Vol. 9 No. 6 437
Basics of Compounding for Pediatric Patients: Commonly Prescribed Oral Liquid Formulations, Vehicles, and Stock Solutions Vol. 9 No. 6 456
PostScription: Compounding Pharmacies and the Successful Treatment of Autism Vol. 9 No. 6 487
Calculations Vol. 9 No. 1 57
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Vol. 9 No. 1 82
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid Vol. 8 No. 6 458
Domperidone in Lactation: Use as a Galactagogue Vol. 8 No. 5 329
Head to Toe Solutions: A Quick Review of Current Therapies Vol. 8 No. 5 345
Book and Literature Reviews Vol. 8 No. 4 244
Gag Tablet Lollipops Vol. 8 No. 3 184
Amiodarone HCl 5-mg/mL Oral Liquid Vol. 8 No. 3 214
Atenolol 2-mg/mL Oral Liquid Vol. 8 No. 3 215
Glycopyrrolate 0.5-mg/mL Oral Liquid Vol. 8 No. 3 218
Flucytosine 10-mg/mL Oral Liquid Vol. 8 No. 2 134
Griseofulvin 25-mg/mL Oral Liquid Vol. 8 No. 2 135
Stomatitis Mouthwash Vol. 8 No. 2 140
Tacrolimus 0.5-mg/mL Oral Liquid Vol. 8 No. 2 141
Tiagabine 1-mg/mL Oral Liquid Vol. 8 No. 2 142
Sulfasalazine 250-mg/5-mL Oral Liquid Vol. 7 No. 6 474
Stability of Two Concentrations of Tiagabine in an Extemporaneously Compounded Suspension Vol. 7 No. 6 485
Thioridazine HCl 100-mg/mL Concentrated Solution Vol. 7 No. 5 381
Isoniazid 10-mg/mL Oral Solution Vol. 7 No. 5 376
Ursodiol 150-mg Capsules Vol. 7 No. 5 382
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Vol. 7 No. 5 394
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Vol. 7 No. 4 313
Pediatric Dermatitis Vol. 6 No. 6 419
Excerpts from and Reviews of Current Published Literature: Pediatric Medications Vol. 6 No. 6 423
Book Reviews: Compounding for Pediatric Patients Vol. 6 No. 6 424
Caffeine and Sodium Benzoate 250-mg/mL Injection Vol. 6 No. 6 449
Dimenhydrinate 50-mg/mL Injection Vol. 6 No. 6 451
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Vol. 6 No. 5 367
Topical Secretin for the Treatment of Autism Vol. 5 No. 6 436
Basics of Compounding: Suspensions Vol. 5 No. 4 294
Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Sugar-Free Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Spironolactone Oral Suspension 2-mg/mL Vol. 5 No. 4 297
Progesterone Oral Suspension 40-mg/mL Vol. 5 No. 4 297
Xanthan Gum Oral Suspension Vehicle 0.3% Vol. 5 No. 4 297
Pediatric Preoperative Cocktail Injection Vol. 5 No. 4 306
The Basics of Compounding Emulsions, Part 2 Vol. 5 No. 3 198
The Basics of Compounding Emulsions, Part 1 Vol. 5 No. 2 120
Pediatric Compounding: Coloring Outside the Lines Vol. 5 No. 1 6
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients Vol. 5 No. 1 9
Flavoring: Compounding a Treat Vol. 5 No. 1 13
Autism in Children Vol. 5 No. 1 18
Methylphenidate in the Treatment of Attention Deficit Disorders Vol. 5 No. 1 21
A Pediatric Miscellany: Excerpts from and Reviews of Current Published Literature Vol. 5 No. 1 23
Compounding in History: Pediatric Considerations Vol. 5 No. 1 30
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Vol. 5 No. 1 38
Cholestyramine 6.5% Ointment Vol. 5 No. 1 42
Ivermectin 0.8% Creme Rinse Vol. 5 No. 1 43
Lidocaine HCl 4%-Epinephrine HCl 0.05%-Tetracaine HCl 0.5% Topical Gel Vol. 5 No. 1 44
Lorazepam 1-mg Chewable Gummy Gels Vol. 5 No. 1 45
Metronidazole Benzoate 400-mg/5-mL Oral Suspension Vol. 5 No. 1 46
Natural Head Lice Repellant Spray Vol. 5 No. 1 48
Niacinamide 4% Acne Gel Vol. 5 No. 1 49
Promethazine HCl 50-mg/mL in PLO Gel Vol. 5 No. 1 51
Basics of Compounding: Compounding Suppositories: Part I - Theoretical Considerations Vol. 4 No. 4 289
Ondansetron HCl 8-mg/mL in PLO Vol. 4 No. 4 305
Compounding Ear, Nose and Throat Preparations Vol. 4 No. 3 164
Xylitol in the Prevention of Otitis Media Vol. 4 No. 3 171
Sildenafil 0.2% Otic Drops Vol. 4 No. 3 175
Amphotericin B 100-mg Troches Vol. 4 No. 3 208
Nystatin 250,000-Unit and/or Tetracaine HCl 0.025% Popsicles Vol. 4 No. 3 214
Basics of Compounding: Compounding Solutions Vol. 4 No. 2 122
Sugar-Free Suspension Structured Vehicle, USP Vol. 4 No. 2 136
The Basics of Compounding: Compounding Hard, Soft and Chewable Troches/Lozenges/Drops Vol. 3 No. 6 461
Linguet Base (Soft Lozenge) Vol. 3 No. 6 462
Sorbitol Based Hard Lozenges Vol. 3 No. 6 462
Sucrose Based Hard Lozenges Vol. 3 No. 6 462
Polyethylene Glycol (PEG) Troches (Soft Lozenges) Vol. 3 No. 6 463
Polyethylene Glycol (PEG) Troches with Suspending Agent (Soft Lozenges) Vol. 3 No. 6 463
Chewable Lozenges Vol. 3 No. 6 464
Methotrexate 2.5-mg/5-mL Oral Liquid Vol. 3 No. 6 474
Extemporaneous Formulations in Pediatric Patients Vol. 3 No. 4 274
Analysis of Extemporaneous Alprostadil Formulations Vol. 3 No. 2 148
Oral Ulceration Mouthwash Vol. 3 No. 1 10
Alternatives for the Lactose-Intolerant Patient Vol. 2 No. 6 412
Pediatric Central Parenteral Nutrition Solution Vol. 2 No. 5 368
Pediatric Central Parenteral Nutrition Solution with Heparin Vol. 2 No. 5 369
Pediatric Peripheral Parenteral Nutrition Solution Vol. 2 No. 5 370
Malathion Topical Lotion: Therapy for Resistant Head Lice Vol. 2 No. 4 268
Compatibility and Stability of Ranitidine Hydrochloride with Six Cephalosporins During Simulated Y-Site Administration Vol. 2 No. 4 318
Tetracaine HCl 1%, Epinephrine HCl 0.025% and Cocaine HCl 4% Topical Solution and Gel Vol. 2 No. 2 159
Vehicles for Compounding Oral Liquids: Some Practical Considerations Vol. 2 No. 2 160
Ondansetron Suppositories: Extemporaneous Preparation, Drug Release, Stability and Flux through Rabbit Rectal Membrane Vol. 2 No. 1 83
Ketoconazole 20-mg/mL Oral Liquid Vol. 1 No. 6 414
Baclofen 10-mg/mL Oral Liquid Vol. 1 No. 5 321
Captopril 0.75-mg/mL Oral Liquid Vol. 1 No. 5 322
Diltiazem HCl 12-mg/mL Oral Suspension Vol. 1 No. 5 323
Stability of Bethanechol Chloride Oral Liquid Dosage Forms Vol. 1 No. 4 278
Allopurinol 20-mg/mL Oral Liquid Vol. 1 No. 3 174
Dipyridamole 10-mg/mL Oral Liquid Vol. 1 No. 3 176
Labetalol HCl 40-mg/mL Oral Liquid Vol. 1 No. 3 179
Metoprolol Tartrate 10-mg/mL Oral Liquid Vol. 1 No. 3 180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Vol. 1 No. 3 183
Spironolactone 25-mg/mL Oral Liquid Vol. 1 No. 3 184
Verapamil HCl 50-mg/mL Oral Liquid Vol. 1 No. 3 188
The Formulation Development and Stability of Spironolactone Suspension Vol. 1 No. 3 195
The Formulation Development and Stability of Metronidazole Suspension Vol. 1 No. 3 200
Metronidazole 15-mg/mL Suspension Vol. 1 No. 3 202
Compounding for the Pediatric Patient Vol. 1 No. 2 84
Attention Deficit Hyperactivity Disorder Vol. 1 No. 2 87
Flavors and Flavoring Vol. 1 No. 2 90
Compounded Suppositories and Pharmaceutical Care Vol. 1 No. 2 93
Acetazolamide 25-mg/mL Oral Liquid Vol. 1 No. 2 101
Azathioprine 50-mg/mL Oral Liquid Vol. 1 No. 2 102
Flecainide Acetate 20-mg/mL Oral Liquid Vol. 1 No. 2 103
Methylcellulose 1% to 5% Solutions Vol. 1 No. 2 104
Methylcellulose Oral-Liquid Vehicles Vol. 1 No. 2 105
Pediatric Chewable Gummy Gel Base Vol. 1 No. 2 106
Pediatric Chocolate Troche Base Vol. 1 No. 2 106
Pediatric Chewable Gummy Gels Vol. 1 No. 2 107
Pediatric Chocolate Troche Vol. 1 No. 2 108
Nystatin Popsicles Vol. 1 No. 2 109
Procainamide HCl 50-mg/mL Oral Liquid Vol. 1 No. 2 110
Syrup NF Vol. 1 No. 2 111
Tetracaine 20-mg Lollipops Vol. 1 No. 2 112
Tetracycline Compound Troche Vol. 1 No. 2 113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Vol. 1 No. 2 114
Omeprazole (Prilosec) in the Atypical Patient, Administration of Vol. 1 No. 1 13
HDDM Hard Troche Vol. 1 No. 1 29
HDDM Soft Troche Vol. 1 No. 1 30
HDDM Sugar Troche Vol. 1 No. 1 30
Metoclophen Nausea Suppositories Vol. 1 No. 1 31
Metoclophen-Modified Nausea Suppositories Vol. 1 No. 1 31
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup compounded from commercial tablets Vol. 1 No. 1 60

GERIATRICS RELATED ARTICLES
Title (Click for Details) Vol/Issue Page
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Vol. 19 No. 1 6
Treatment Options for Male Hypogonadism Vol. 17 No. 1 28
Testosterone Levels in an Aging Population: Screen, Measure, and Restore Vol. 15 No. 2 102
Clozapine 20-mg/mL Oral Suspension Vol. 14 No. 3 243
PreScription: The Ages of Man Vol. 14 No. 2 92
Emerging Evidence for Androgen Replacement Therapy in Aging Men Vol. 14 No. 2 94
PreScription: Geriatric Compounding: An Opportunity for Pharmacists Vol. 13 No. 6 492
Low Testosterone in Older Men: A Discussion and Review of Literature on Health Consequences of Hypogonadism in the Aging Male Vol. 13 No. 6 494
Compliance to Treatment in Elderly Dysphagic Patients: Potential Benefits of Alternate Dosage Forms Vol. 13 No. 6 498
Marketing the Geriatric Patient Vol. 13 No. 6 538
Calculations Vol. 13 No. 6 545
Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Vol. 13 No. 4 340
Arthritis Epidemiology Impacts Pharmacists Vol. 12 No. 6 476
Intravitreal Bevacizumab for Choroidal Neovascularization in Age-Related Macular Degeneration Vol. 12 No. 1 8
Calculations Vol. 11 No. 1 68
Carbidopa 1.25-mg/mL Oral Liquid Vol. 11 No. 1 70
Clonidine Hydrochloride 0.1-mg/mL Oral Liquid Vol. 11 No. 1 71
Methyldopa 25-mg/mL Oral Liquid Vol. 11 No. 1 75
Metolazone 1-mg/mL Oral Liquid Vol. 11 No. 1 76
Propranolol Hydrochloride 1-mg/mL Oral Liquid Vol. 10 No. 4 304
Stability of an Extemporaneously Compounded Propylthiouracil Suspension Vol. 9 No. 1 82
Book and Literature Reviews Vol. 8 No. 4 244
Case Report: Wound Care of a Diabetic Foot Ulcer Vol. 8 No. 4 265
Current Topical Treatments in Wound Healing - Part 1 Vol. 8 No. 4 269
Atropine 1-mg Gelatin Troches Vol. 8 No. 3 184
Clonidine HCl 0.2%/Gabapentin 6%/Ketamine HCl 10% in Pluronic Lecithin Organogel (PLO) Vol. 8 No. 3 185
Pain Management in the Elderly Vol. 8 No. 3 187
Amiodarone HCl 5-mg/mL Oral Liquid Vol. 8 No. 3 214
Atenolol 2-mg/mL Oral Liquid Vol. 8 No. 3 215
Glycopyrrolate 0.5-mg/mL Oral Liquid Vol. 8 No. 3 218
Flucytosine 10-mg/mL Oral Liquid Vol. 8 No. 2 134
Griseofulvin 25-mg/mL Oral Liquid Vol. 8 No. 2 135
Stomatitis Mouthwash Vol. 8 No. 2 140
Tacrolimus 0.5-mg/mL Oral Liquid Vol. 8 No. 2 141
Tiagabine 1-mg/mL Oral Liquid Vol. 8 No. 2 142
Extemporaneous Formulation and Stability Testing of Mexiletine HCl Solution Vol. 8 No. 2 147
Ergoloid Mesylate 1-mg/mL Oral Liquid Vol. 7 No. 6 470
Perphenazine 2.5-mg/5-mL Syrup Vol. 7 No. 6 473
Sulfasalazine 250-mg/5-mL Oral Liquid Vol. 7 No. 6 474
Thioridazine HCl 100-mg/mL Concentrated Solution Vol. 7 No. 5 381
Isoniazid 10-mg/mL Oral Solution Vol. 7 No. 5 376
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride Vol. 7 No. 5 389
Educating the Caregiver and Community Pharmacist To Facilitate Provision of Consistent Compounded Medications from the Inpatient to Ambulatory Settings Vol. 7 No. 5 394
Stability of Hydralazine HCl in Both Flavored and Nonflavored Extemporaneous Preparations Vol. 7 No. 4 313
Levofloxacin 250-mg/5mL Oral Liquid Vol. 7 No. 1 60
Ofloxacin 250-mg/5-mL Oral Liquid Vol. 7 No. 1 60
Erythromycin 400-mg/mL and Rifampin 50-mg/mL Oral Liquid Vol. 6 No. 5 367
Mild Laxative Vol. 6 No. 3 185
Liver Pills for All Obstructions of the Liver, Gall Ducts, and Bowel Vol. 6 No. 3 185
Compounding for Geriatrics Patients Vol. 6 No. 3 168
Estrogen Replacement Therapy in the Treatment of Alzheimer's Disease Vol. 6 No. 3 171
Book Reviews: Wellness, Nutrition and Geriatrics Vol. 6 No. 3 180
Carbidopa 2-mg/mL and Levodopa 250-mg/mL Oral Suspension Vol. 6 No. 3 202
Bioidentical Hormones in the Treatment of Osteoporosis Vol. 5 No. 5 339
Basics of Compounding: Suspensions Vol. 5 No. 4 294
Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Sugar-Free Suspension Structured Vehicle, USP Vol. 5 No. 4 296
Spironolactone Oral Suspension 2-mg/mL Vol. 5 No. 4 297
Progesterone Oral Suspension 40-mg/mL Vol. 5 No. 4 297
Xanthan Gum Oral Suspension Vehicle 0.3% Vol. 5 No. 4 297
The Basics of Compounding Emulsions, Part 2 Vol. 5 No. 3 198
The Basics of Compounding Emulsions, Part 1 Vol. 5 No. 2 120
Electrolyte and Rehydration Powder for Solution-Example of Powder Formulations Vol. 5 No. 1 38
Milk of Magnesia Concentrate, Unflavored Vol. 5 No. 1 47
Nicotinamide-Adenine Dinucleotide (NADH) in Parkinson's Disease and Alzheimer's Disease Vol. 4 No. 4 276
Amphotericin B 100-mg Troches Vol. 4 No. 3 208
Saliva Substitute for Dry Mouth/Throat Vol. 4 No. 3 215
Basics of Compounding: Compounding Solutions Vol. 4 No. 2 122
Osteoarthritis: Other Options Vol. 3 No. 6 433
Methotrexate 2.5-mg/5-mL Oral Liquid Vol. 3 No. 6 474
Alternatives for the Lactose-Intolerant Patient Vol. 2 No. 6 412
Treatment of Skin Aging with Topical Estrogens Vol. 2 No. 4 270
Stability of Ciprofloxacin in Extemporaneous Oral Liquid Dosage Form Vol. 2 No. 4 314
Vehicles for Compounding Oral Liquids: Some Practical Considerations Vol. 2 No. 2 160
Estrogen in the Treatment and Prevention of Alzheimer's Disease Vol. 2 No. 1 24
Ketoconazole 20-mg/mL Oral Liquid Vol. 1 No. 6 414
Baclofen 10-mg/mL Oral Liquid Vol. 1 No. 5 321
Captopril 0.75-mg/mL Oral Liquid Vol. 1 No. 5 322
Diltiazem HCl 12-mg/mL Oral Suspension Vol. 1 No. 5 323
Metolazone 1-mg/mL Oral Suspension Vol. 1 No. 5 329
Stability of Bethanechol Chloride Oral Liquid Dosage Forms Vol. 1 No. 4 278
Creative Compounding for the Geriatric Patient Vol. 1 No. 3 147
Drug Products and Drug Packaging for the Elderly Vol. 1 No. 3 150
Common Diseases of the Elderly Vol. 1 No. 3 152
Allopurinol 20-mg/mL Oral Liquid Vol. 1 No. 3 174
Dipyridamole 10-mg/mL Oral Liquid Vol. 1 No. 3 176
Labetalol HCl 40-mg/mL Oral Liquid Vol. 1 No. 3 179
Metoprolol Tartrate 10-mg/mL Oral Liquid Vol. 1 No. 3 180
Spironolactone 5-mg/mL with Hydrochlorothiazide 5-mg/mL Oral Liquid Vol. 1 No. 3 183
Spironolactone 25-mg/mL Oral Liquid Vol. 1 No. 3 184
Verapamil HCl 50-mg/mL Oral Liquid Vol. 1 No. 3 188
Metronidazole 15-mg/mL Suspension Vol. 1 No. 3 202
Acetazolamide 25-mg/mL Oral Liquid Vol. 1 No. 2 101
Azathioprine 50-mg/mL Oral Liquid Vol. 1 No. 2 102
Flecainide Acetate 20-mg/mL Oral Liquid Vol. 1 No. 2 103
Methylcellulose 1% to 5% Solutions Vol. 1 No. 2 104
Methylcellulose Oral-Liquid Vehicles Vol. 1 No. 2 105
Procainamide HCl 50-mg/mL Oral Liquid Vol. 1 No. 2 110
Syrup NF Vol. 1 No. 2 111
Tetracaine 20-mg Lollipops Vol. 1 No. 2 112
Tetracycline Compound Troche Vol. 1 No. 2 113
Xanthan Gum Suspension Vehicle (0.2% to 0.5%) Vol. 1 No. 2 114
Stability of Allopurinol Suspension Compounded from Tablets Vol. 1 No. 2 128
Hospice Care and the Pharmacist Vol. 1 No. 1 11
Omeprazole (Prilosec) in the Atypical Patient, Administration of Vol. 1 No. 1 13
Stability of an Extemporaneously Formulated Levothyroxine Sodium Syrup compounded from commercial tablets Vol. 1 No. 1 60